| 前收盘价格 | 5.84 |
| 收盘价格 | 5.84 |
| 成交量 | 108,297 |
| 平均成交量 (3个月) | 1,241,811 |
| 市值 | 224,476,192 |
| 价格/销量 (P/S) | 0.530 |
| 股市价格/股市净资产 (P/B) | 0.970 |
| 52周波幅 | |
| 利润日期 | 5 May 2025 - 9 May 2025 |
| 营业毛利率 | -27.77% |
| 营业利益率 (TTM) | -21.79% |
| 稀释每股收益 (EPS TTM) | -3.06 |
| 季度收入增长率 (YOY) | -9.10% |
| 总债务/股东权益 (D/E MRQ) | 108.86% |
| 流动比率 (MRQ) | 4.62 |
| 营业现金流 (OCF TTM) | -19.44 M |
| 杠杆自由现金流 (LFCF TTM) | -4.77 M |
| 资产报酬率 (ROA TTM) | -9.95% |
| 股东权益报酬率 (ROE TTM) | -43.29% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 看跌 | 混合的 |
| Medical Devices (全球的) | 看跌 | 混合的 | |
| 股票 | Nevro Corp. | 看涨 | 看跌 |
AIStockmoo 评分
-0.6
| 分析师共识 | 2.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 0.0 |
| 平均 | -0.63 |
|
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 2.84% |
| 机构持股比例 | 110.59% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Palo Alto Investors Lp | 31 Dec 2024 | 750,371 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合